Man Group
INSM icon

Man Group’s Insmed INSM Stock Holding History

Man Group’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.64M Sell
52,857
-73,983
-58% -$8.96M 0.01% 1078
2026
Q1 		$20.7M Buy
126,840
+8,479
+7% +$1.3M 0.04% 483
2025
Q4 		$20.6M Buy
118,361
+33,192
+39% +$6.06M 0.04% 499
2025
Q3 		$12.3M Buy
+85,169
New +$10.4M 0.02% 697
2025
Q1 		– Sell
-28,963
Closed -$2M – 2274
2024
Q4 		$2M Sell
28,963
-586,983
-95% -$42.3M 0.01% 1312
2024
Q3 		$45M Buy
615,946
+575,513
+1,423% +$42.5M 0.12% 215
2024
Q2 		$2.71M Buy
+40,433
New +$1.57M 0.01% 1245
2024
Q1 		– Sell
-56,568
Closed -$1.75M – 2192
2023
Q4 		$1.75M Buy
+56,568
New +$1.47M ﹤0.01% 1310
2022
Q2 		– Sell
-9,032
Closed -$212K – 2227
2022
Q1 		$212K Sell
9,032
-24,700
-73% -$574K ﹤0.01% 1918
2021
Q4 		$919K Buy
33,732
+1,773
+6% +$50.7K ﹤0.01% 1352
2021
Q3 		$880K Buy
31,959
+4,214
+15% +$111K ﹤0.01% 1371
2021
Q2 		$790K Sell
27,745
-76,819
-73% -$2.28M ﹤0.01% 1440
2021
Q1 		$3.56M Sell
104,564
-72,037
-41% -$2.75M 0.02% 858
2020
Q4 		$5.88M Sell
176,601
-69,405
-28% -$2.54M 0.03% 724
2020
Q3 		$7.91M Buy
246,006
+209,325
+571% +$6.02M 0.03% 578
2020
Q2 		$1.01M Buy
+36,681
New +$870K 0.01% 1268
2020
Q1 		– Sell
-381,763
Closed -$9.12M – 1735
2019
Q4 		$9.12M Sell
381,763
-1,059
-0.3% -$21.5K 0.03% 734
2019
Q3 		$6.75M Sell
382,822
-73,914
-16% -$1.43M 0.03% 734
2019
Q2 		$11.7M Buy
456,736
+104,829
+30% +$2.92M 0.04% 558
2019
Q1 		$10.2M Sell
351,907
-184,854
-34% -$4.79M 0.04% 551
2018
Q4 		$7.04M Buy
+536,761
New +$8.56M 0.03% 599
2018
Q3 		– Sell
-52,485
Closed -$1.24M – 2151
2018
Q2 		$1.24M Buy
+52,485
New +$1.35M 0.01% 1539

Other funds holding INSM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Man Group's INSM Position: Q2 2026 in Review

Man Group reduced its Insmed (INSM) stake by 58% in Q2 2026, selling an estimated $8.96M and leaving 52,857 shares worth $5.64M. The position accounts for 0.01% of the portfolio, ranked #1078.

Man Group first reported a position in INSM in Q2 2018 and has held it in 22 quarters since. The position peaked at $45M in Q3 2024. 663 funds tracked by Wall St. Rank hold INSM as of Q2 2026.

  • Man Group held 52,857 shares of Insmed worth $5.64M as of Q2 2026.
  • Man Group sold 73,983 Insmed shares in Q2 2026, an estimated $8.96M.
  • Insmed made up 0.01% of Man Group's portfolio in Q2 2026, its #1078 holding.
  • Man Group first reported a position in Insmed in Q2 2018 and has held it in 22 quarters since.
  • Man Group's Insmed position peaked at $45M in Q3 2024.
  • 663 funds tracked by Wall St. Rank held Insmed as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.